Acacia Pharma
Acacia Pharma is a pharmaceutical company focused on hospital-based supportive care. Supportive care is the management of the symptoms of a disease or condition, and the side-effects of the treatments of that disease or condition. Acacia primarily focuses on cancer supportive care, an area which is considered to have come of age.
Acacia has a lower risk product discovery and development capability which delivers supportive care product opportunities based on established drugs. This approach allows Acacia to capitalise on publicly available information, thereby lowering development risk, time and cost compared to new chemical or molecular entities. The company aims to retain product commercialisation rights, enabling it to deliver maximum value from its assets.
Acacia operates a virtual business model. It has an experienced management team, members of which have successfully conceived, managed and exited similar businesses. The team has extensive expertise in all areas considered core to the business and is complemented by a network of industry consultants.